• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Hospitalized Children With Familial Hypercholesterolemia and COVID-19: A Case for Preventive Anticoagulation.

作者信息

Vuorio Alpo, Raal Frederick, Kovanen Petri T

机构信息

Mehiläinen Airport Health Centre, Vantaa, Finland.

Department of Forensic Medicine, University of Helsinki, Helsinki, Finland.

出版信息

Front Cardiovasc Med. 2021 Apr 20;8:657719. doi: 10.3389/fcvm.2021.657719. eCollection 2021.

DOI:10.3389/fcvm.2021.657719
PMID:33959645
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8093379/
Abstract
摘要

相似文献

1
Hospitalized Children With Familial Hypercholesterolemia and COVID-19: A Case for Preventive Anticoagulation.患有家族性高胆固醇血症和新冠病毒病的住院儿童：预防性抗凝治疗的一个案例
Front Cardiovasc Med. 2021 Apr 20;8:657719. doi: 10.3389/fcvm.2021.657719. eCollection 2021.
2
Intensity of anticoagulation and survival in patients hospitalized with COVID-19 pneumonia.新冠病毒肺炎住院患者的抗凝强度与生存率
Thromb Res. 2020 Dec;196:375-378. doi: 10.1016/j.thromres.2020.09.030. Epub 2020 Sep 23.
3
D-Dimer-Driven Anticoagulation Reduces Mortality in Intubated COVID-19 Patients: A Cohort Study With a Propensity-Matched Analysis.D-二聚体驱动的抗凝治疗可降低插管的COVID-19患者的死亡率：一项倾向匹配分析的队列研究。
Front Med (Lausanne). 2021 Feb 4;8:631335. doi: 10.3389/fmed.2021.631335. eCollection 2021.
4
Pathogenesis-directed therapy of 2019 novel coronavirus disease.针对 2019 新型冠状病毒病的发病机制导向治疗。
J Med Virol. 2021 Mar;93(3):1320-1342. doi: 10.1002/jmv.26610. Epub 2020 Nov 10.
5
Child-Parent Familial Hypercholesterolemia Screening in Primary Care.儿童-父母家族性高胆固醇血症的初级保健筛查。
N Engl J Med. 2016 Oct 27;375(17):1628-1637. doi: 10.1056/NEJMoa1602777.
6
Fibrinogen and D-dimer variances and anticoagulation recommendations in Covid-19: current literature review.新冠病毒肺炎中纤维蛋白原和D-二聚体的变化及抗凝建议：当前文献综述
Rev Assoc Med Bras (1992). 2020 Jun;66(6):842-848. doi: 10.1590/1806-9282.66.6.842. Epub 2020 Jul 20.
7
D-Dimer as a Prognostic Indicator in Critically Ill Patients Hospitalized With COVID-19 in Leishenshan Hospital, Wuhan, China.D-二聚体作为中国武汉雷神山医院收治的新冠肺炎危重症患者的预后指标
Front Pharmacol. 2020 Dec 21;11:600592. doi: 10.3389/fphar.2020.600592. eCollection 2020.
8
Venous Thromboembolism in Hospitalized COVID-19 Patients.住院 COVID-19 患者中的静脉血栓栓塞症。
Am J Ther. 2020 Nov/Dec;27(6):e599-e610. doi: 10.1097/MJT.0000000000001295.
9
Venous Thromboembolism among Hospitalized Patients with COVID-19 Undergoing Thromboprophylaxis: A Systematic Review and Meta-Analysis.接受血栓预防的COVID-19住院患者的静脉血栓栓塞：一项系统评价和荟萃分析
J Clin Med. 2020 Aug 3;9(8):2489. doi: 10.3390/jcm9082489.
10
Statins for children with familial hypercholesterolemia.用于家族性高胆固醇血症儿童的他汀类药物。
Cochrane Database Syst Rev. 2014 Jul 23(7):CD006401. doi: 10.1002/14651858.CD006401.pub3.

引用本文的文献

1
Hypercholesterolemia and COVID-19: Statins for Lowering the Risk of Venous Thromboembolism.高胆固醇血症与2019冠状病毒病：他汀类药物用于降低静脉血栓栓塞风险
Front Cardiovasc Med. 2021 Oct 13;8:711923. doi: 10.3389/fcvm.2021.711923. eCollection 2021.

本文引用的文献

1
Systemic thrombosis in a large cohort of COVID-19 patients despite thromboprophylaxis: A retrospective study.尽管进行了血栓预防，但在大型 COVID-19 患者队列中仍发生全身性血栓：一项回顾性研究。
Thromb Res. 2021 Mar;199:132-142. doi: 10.1016/j.thromres.2020.12.024. Epub 2021 Jan 7.
2
PCSK9 inhibitors for COVID-19: an opportunity to enhance the antiviral action of interferon in patients with hypercholesterolaemia.用于治疗新冠肺炎的前蛋白转化酶枯草溶菌素9（PCSK9）抑制剂：提高高胆固醇血症患者干扰素抗病毒作用的契机
J Intern Med. 2021 May;289(5):749-751. doi: 10.1111/joim.13210. Epub 2020 Dec 19.
3
COVID-19-Associated Nonocclusive Fibrin Microthrombi in the Heart.COVID-19 相关非闭塞性纤维蛋白微血栓形成于心脏。
Circulation. 2021 Jan 19;143(3):230-243. doi: 10.1161/CIRCULATIONAHA.120.050754. Epub 2020 Nov 16.
4
Consensus-based clinical recommendations and research priorities for anticoagulant thromboprophylaxis in children hospitalized for COVID-19-related illness.基于共识的临床建议和研究重点，用于因 COVID-19 相关疾病住院的儿童的抗凝血栓预防。
J Thromb Haemost. 2020 Nov;18(11):3099-3105. doi: 10.1111/jth.15073.
5
Are children with SARS-CoV-2 infection at high risk for thrombosis? Viscoelastic testing and coagulation profiles in a case series of pediatric patients.儿童感染 SARS-CoV-2 是否有发生血栓的高风险？儿童患者病例系列中的黏弹性检测和凝血特征。
Pediatr Blood Cancer. 2020 Dec;67(12):e28737. doi: 10.1002/pbc.28737.
6
COVID-19 is, in the end, an endothelial disease.COVID-19 归根结底是一种血管内皮疾病。
Eur Heart J. 2020 Sep 1;41(32):3038-3044. doi: 10.1093/eurheartj/ehaa623.
7
Evolocumab in Pediatric Heterozygous Familial Hypercholesterolemia.依洛尤单抗在儿科杂合子家族性高胆固醇血症中的应用。
N Engl J Med. 2020 Oct 1;383(14):1317-1327. doi: 10.1056/NEJMoa2019910. Epub 2020 Aug 29.
8
Incidence of venous and arterial thromboembolic complications in COVID-19: A systematic review and meta-analysis.新型冠状病毒肺炎患者静脉和动脉血栓栓塞并发症的发生率：一项系统评价和荟萃分析。
Thromb Res. 2020 Dec;196:27-30. doi: 10.1016/j.thromres.2020.08.022. Epub 2020 Aug 11.
9
COVID-19 in 7780 pediatric patients: A systematic review.7780例儿科患者的新冠病毒病：一项系统评价
EClinicalMedicine. 2020 Jun 26;24:100433. doi: 10.1016/j.eclinm.2020.100433. eCollection 2020 Jul.
10
Prevention of endothelial dysfunction and thrombotic events in COVID-19 patients with familial hypercholesterolemia.预防家族性高胆固醇血症的新冠肺炎患者出现内皮功能障碍和血栓形成事件。
J Clin Lipidol. 2020 Sep-Oct;14(5):617-618. doi: 10.1016/j.jacl.2020.06.006. Epub 2020 Jun 15.